临床相关特征 | 单因素分析 | 多因素分析 | ||
OR (95% CI) | P值 | OR (95% CI) | P值 | |
接种疫苗后天数 | 0.986 (0.974~0.998) | 0.027 | 0.996 (0.982~1.010) | 0.585 |
年龄(岁) | 0.970 (0.939~1.002) | 0.071 | ||
体重指数(kg/m2) | 1.068 (0.953~1.204) | 0.263 |
|
|
疫苗类型 |
|
|
|
|
BBIBP-CorV | Ref |
|
|
|
CoronaVac | 0.517 (0.247~−1.076) | 0.078 |
|
|
Zhifei Longcom, China | 0.480 (0.188~−1.234) | 0.123 |
|
|
性别 |
|
|
|
|
女性 | Ref |
|
|
|
男性 | 0.508 (0.254~0.010) | 0.05 | 3.113 (1.355~7.528) | 0.008 |
TNM分期 |
|
|
|
|
TNM1 | Ref |
|
|
|
TNM2 | 0.479 (0.161~1.256) | 0.1537 |
|
|
TNM3 | 0.351 (0.103~1.094) | 0.0789 |
|
|
TNM4 | 0.448 (0.116~1.664) | 0.2316 |
|
|
ASA分级 |
|
|
|
|
ASA1 | Ref |
|
|
|
ASA2 | 0.298 (0.064~1.020) | 0.076 | 0.538 (0.107~2.101) | 0.400 |
ASA3 | 0.088 (0.019~0.277) | <0.01 | 0.097 (0.020~0.343) | <0.01 |
积极治疗 |
|
|
|
|
No | Ref |
|
|
|
Yes | 0.225 (0.090, 0.503) | <0.01 | 0.344 (0.115~0.947) | 0.044 |
化疗 |
|
|
|
|
No | Ref |
|
|
|
Yes | 0.260 (0.128, 0.515) | <0.01 | 0.392 (0.164~0.916) | 0.032 |
红细胞计数(1012/L) | 1.312 (0.819~2.129) | 0.262 |
|
|
白细胞计数(109/L) | 0.944 (0.848~1.049) | 0.285 |
|
|
淋巴细胞计数(109/L) | 0.772 (0.455~1.014) | 0.329 |
|
|
白蛋白(g/L) | 1.000 (0.999~1.000) | 0.818 |
|
|
RBD特异性B细胞 | 0.978 (0.933~1.025) | 0.353 |
|
|
静息B细胞 | 0.990 (0.957~1.024) | 0.567 |
|
|
中间B细胞 | 1.004 (0.980~1.028) | 0.740 |
|
|
活化B细胞 | 0.980 (0.943~1.018) | 0.305 |
|
|
非典型B细胞 | 1.017 (0.985~1.052) | 0.306 |
|
|